Accessibility issues or difficulties with this website?
Call 919-962-2073 or email hchsadministration@unc.edu.

Integrating genetics and metabolomics from multi-ethnic and multi-fluid data reveals putative mechanisms for age-related macular degeneration.

TitleIntegrating genetics and metabolomics from multi-ethnic and multi-fluid data reveals putative mechanisms for age-related macular degeneration.
Publication TypePublication
Year2023
AuthorsHan X, Lains I, Li J, Li J, Chen Y, Yu B, Qi Q, Boerwinkle E, Kaplan R, Thyagarajan B, Daviglus M, Joslin CE, Cai J, Guasch-Ferré M, Tobias DK, Rimm E, Ascherio A, Costenbader K, Karlson E, Mucci L, A Eliassen H, Zeleznik O, Miller J, Vavvas DG, Kim IK, Silva R, Miller J, Hu F, Willett W, Lasky-Su J, Kraft P, J Richards B, MacGregor S, Husain D, Liang L
JournalCell Rep Med
Volume4
Issue7
Pagination101085
Date Published2023 Jul 18
ISSN2666-3791
KeywordsAged, Bayes Theorem, genome-wide association study, Humans, Macular Degeneration, Metabolome, Metabolomics
Abstract

Age-related macular degeneration (AMD) is a leading cause of blindness in older adults. Investigating shared genetic components between metabolites and AMD can enhance our understanding of its pathogenesis. We conduct metabolite genome-wide association studies (mGWASs) using multi-ethnic genetic and metabolomic data from up to 28,000 participants. With bidirectional Mendelian randomization analysis involving 16,144 advanced AMD cases and 17,832 controls, we identify 108 putatively causal relationships between plasma metabolites and advanced AMD. These metabolites are enriched in glycerophospholipid metabolism, lysophospholipid, triradylcglycerol, and long chain polyunsaturated fatty acid pathways. Bayesian genetic colocalization analysis and a customized metabolome-wide association approach prioritize putative causal AMD-associated metabolites. We find limited evidence linking urine metabolites to AMD risk. Our study emphasizes the contribution of plasma metabolites, particularly lipid-related pathways and genes, to AMD risk and uncovers numerous putative causal associations between metabolites and AMD risk.

DOI10.1016/j.xcrm.2023.101085
Alternate JournalCell Rep Med
PubMed ID37348500
PubMed Central IDPMC10394104
Grant ListR01 AR049880 / AR / NIAMS NIH HHS / United States
U01 CA176726 / CA / NCI NIH HHS / United States
U01 CA167552 / CA / NCI NIH HHS / United States
R01 EY030088 / EY / NEI NIH HHS / United States
R00 DK122128 / DK / NIDDK NIH HHS / United States
R01 CA049449 / CA / NCI NIH HHS / United States
R01 CA067262 / CA / NCI NIH HHS / United States
UM1 CA186107 / CA / NCI NIH HHS / United States
MS#: 
0892
Manuscript Lead/Corresponding Author Affiliation: 
Affiliated Investigator - Not at HCHS/SOL site
ECI: 
Yes
Manuscript Affiliation: 
Field Center: Bronx (Einstein College of Medicine)
Manuscript Status: 
Published